Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review
Rutherford, George W., Horvath, Hacsi, Menéndez-Arias, LuisVolume:
11
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0162775
Date:
October, 2016
File:
PDF, 1.31 MB
english, 2016